BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Contreras H, Wussow F, Fernández-Alarcón C, Bierle C, Nguyen J, Diamond DJ, Schleiss MR. MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission. Vaccines (Basel) 2019;7:E182. [PMID: 31739399 DOI: 10.3390/vaccines7040182] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pursell T, Spencer Clinton JL, Tan J, Peng R, Ling PD. Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice. PLoS One 2022;17:e0265424. [PMID: 35312707 DOI: 10.1371/journal.pone.0265424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Fernández-Alarcón C, Buchholz G, Contreras H, Wussow F, Nguyen J, Diamond DJ, Schleiss MR. Protection against Congenital CMV Infection Conferred by MVA-Vectored Subunit Vaccines Extends to a Second Pregnancy after Maternal Challenge with a Heterologous, Novel Strain Variant. Viruses 2021;13:2551. [PMID: 34960820 DOI: 10.3390/v13122551] [Reference Citation Analysis]
3 Schleiss MR, Fernández-Alarcón C, Hernandez-Alvarado N, Wang JB, Geballe AP, McVoy MA. Inclusion of the Guinea Pig Cytomegalovirus Pentameric Complex in a Live Virus Vaccine Aids Efficacy against Congenital Infection but Is Not Essential for Improving Maternal and Neonatal Outcomes. Viruses 2021;13:2370. [PMID: 34960639 DOI: 10.3390/v13122370] [Reference Citation Analysis]
4 Esposito S, Chiopris G, Messina G, D'Alvano T, Perrone S, Principi N. Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art. Vaccines (Basel) 2021;9:523. [PMID: 34069321 DOI: 10.3390/vaccines9050523] [Reference Citation Analysis]
5 Singh T, Otero CE, Li K, Valencia SM, Nelson AN, Permar SR. Vaccines for Perinatal and Congenital Infections-How Close Are We? Front Pediatr 2020;8:569. [PMID: 33384972 DOI: 10.3389/fped.2020.00569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Schleiss MR, Diamond DJ. Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection. Vaccines (Basel) 2020;8:E526. [PMID: 32937764 DOI: 10.3390/vaccines8030526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gerna G, Lilleri D. Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine Development. Vaccines (Basel) 2020;8:E194. [PMID: 32340180 DOI: 10.3390/vaccines8020194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cui X, Cao Z, Wang S, Adler SP, McVoy MA, Snapper CM. Immunization with Human Cytomegalovirus Core Fusion Machinery and Accessory Envelope Proteins Elicit Strong Synergistic Neutralizing Activities. Vaccines (Basel) 2020;8:E179. [PMID: 32294946 DOI: 10.3390/vaccines8020179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Choi KY, El-Hamdi NS, McGregor A. Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells. J Gen Virol 2020;101:426-39. [PMID: 32068527 DOI: 10.1099/jgv.0.001394] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]